rct
    2010

    Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study

    Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M

    Published in Journal of Clinical Gastroenterology

    Methodology

    Randomized double-blind dose-finding study of delayed-release phosphatidylcholine in chronic active ulcerative colitis

    Key Findings

    Clinical remission and mucosal healing improved with increasing phosphatidylcholine doses compared with baseline

    Conclusions

    Dose-dependent benefit supports further development of delayed-release phosphatidylcholine

    Limitations

    Dose-finding design without an adequately powered placebo comparison

    Supplements Studied

    Clinical remission and mucosal healing improved with increasing phosphatidylcholine doses compared with baseline

    Related Health Concerns

    Ulcerative Colitis

    Study Details

    Year:2010
    Sample Size:60
    Duration:12 weeks
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.